GLP-1 Receptor Agonists, Allostatic Load, and Reframing the Glaucoma Paradigm
- PMID: 40417146
- PMCID: PMC12096885
- DOI: 10.5005/jp-journals-10078-1471
GLP-1 Receptor Agonists, Allostatic Load, and Reframing the Glaucoma Paradigm
Conflict of interest statement
Source of support: Nil Conflict of interest: NoneConflict of interest: None
Similar articles
-
Glucagon-Like Peptide 1 Receptor Agonists - Potential Game Changers in the Treatment of Glaucoma?Front Neurosci. 2022 Feb 21;16:824054. doi: 10.3389/fnins.2022.824054. eCollection 2022. Front Neurosci. 2022. PMID: 35264926 Free PMC article. Review.
-
Glucagon-like peptide 1 receptor agonist use is associated with reduced risk for glaucoma.Br J Ophthalmol. 2023 Feb;107(2):215-220. doi: 10.1136/bjophthalmol-2021-319232. Epub 2021 Aug 19. Br J Ophthalmol. 2023. PMID: 34413054 Free PMC article.
-
Stress, Allostatic Load, and Neuroinflammation: Implications for Racial and Socioeconomic Health Disparities in Glaucoma.Int J Mol Sci. 2024 Jan 29;25(3):1653. doi: 10.3390/ijms25031653. Int J Mol Sci. 2024. PMID: 38338933 Free PMC article. Review.
-
Association Between Glucagon-Like Peptide-1 Receptor Agonists Exposure and Intraocular Pressure Change: GLP-1 Receptor Agonists and Intraocular Pressure Change.Am J Ophthalmol. 2025 Jan;269:255-265. doi: 10.1016/j.ajo.2024.08.030. Epub 2024 Sep 3. Am J Ophthalmol. 2025. PMID: 39237049
-
Hypertension linked to allostatic load: from psychosocial stress to inflammation and mitochondrial dysfunction.Stress. 2019 Mar;22(2):169-181. doi: 10.1080/10253890.2018.1542683. Epub 2018 Dec 14. Stress. 2019. PMID: 30547701 Review.
References
Publication types
LinkOut - more resources
Full Text Sources